MLA 0.00% 8.5¢ medical australia limited

this is ticking all boxes and not many know .

  1. 3,883 Posts.
    lightbulb Created with Sketch. 122
    Part of my previous post ......"Patterson companies. listed on the nasdaq(pdco) has a market cap of four billion $ ..Patterson Veterinary is a division (one of three) of that company ..Patterson Vet. has 21%of the American market, with 245 field professnals spread over 50 states and 140 csr,s working out of 18 branches and a extremly large customer base nation wide..Now they have entered into a partnership with MediVet America(current) a leader in veterinary stem cell technology and regenerative medicine, to distribute stem cell and platelet-rich plasma kits, as well as associated tissue processing equipment to veterinary practices... nationwide"...........................As we know MLA is in the process of acquiring Medivet and in fact own 60% if the deal happens(which will be/has been decided today ) my belief is if that goes thru the 40% remaining will come under MLA,s control pronto ..Now bigger moves are afoot And Im sure MLA will expose to the market as soon as they are signed off. The first one Commences in July (current )And the contract I am posting below is Starting in August in the UK.....................
    2013

    Patterson Companies Expands Strategic Direction for Veterinary Business


    Acquires National Veterinary Services, Largest Veterinary Distributor in United Kingdom

    ST. PAUL, Minn.--(BUSINESS WIRE)-- Patterson Companies, Inc. (Nasdaq: PDCO) today announced another step in the company's strategic vision for its veterinary business. Patterson Companies has agreed to acquire the stock of National Veterinary Services Limited (NVS), a wholly owned subsidiary of Dechra Pharmaceuticals PLC (Dechra) (DPH.L). NVS is the largest veterinary distributor in the United Kingdom providing an array of products and services, including reference laboratory offerings.

    Patterson is focused on building its value-added model in the veterinary market by increasing the company's service offerings, as well as its equipment and technical service strategy, to capture market share as veterinarians expand their practice capabilities to meet heightened pet owner expectations. In line with this overall strategy, the company believes NVS provides an exceptional platform to extend Patterson's strategies into additional geographic markets.

    The Patterson Companies and the Dechra Boards of Directors have unanimously approved a definitive agreement, under which Patterson Companies will acquire all of the outstanding shares of NVS for £87.5 million (approximately US $135 million) in cash. The transaction is subject to approval by Dechra shareholders with a closing date currently scheduled in August 2013. NVS had revenues of more than £315 million for its year ended June 30, 2013. In Patterson's first full year after closing, the acquisition is expected to be accretive to earnings by $0.04 to $0.05 per share, including the impact of one-time and transactional expenses.

    "This agreement reflects our commitment to Patterson Veterinary's strategic direction. Through this acquisition, we are able to expand Patterson Veterinary internationally, providing our industry-leading service to a new market," said Scott P. Anderson, chairman and chief executive officer of Patterson Companies. "Over the past several years, we have seen the strength of Patterson's platform and global network continue to grow. With this acquisition, we will further extend our footprint and increase shareholder value."

    George Henriques, president of Patterson Veterinary, commented, "We are excited to have NVS and the Labs Business join the Patterson group , and are enthused by this unique opportunity to create a powerful global franchise with best-in-class client service in the veterinary market. We see strong growth opportunities as consumers continue to increase the amount they spend on their pets. There are numerous benefits to this transaction, including NVS's long-standing relationships in the U.K. and other markets, their cutting edge customer-facing technology, operational efficiencies and strong operating cash flows."

    NVS will operate as a stand-alone subsidiary of Patterson Companies with Martin Riley serving as managing director. Riley has been managing director of NVS for eight years and has outstanding credentials in the industry. He and the staff at NVS will report administratively to Henriques with limited integration of systems in the near-term, as Patterson continues its previously announced internal systems transformation.

    "We look forward to bringing new innovative and exciting benefits to our customers, adding to our technology platform and expertise to give us market-leading competitive advantage," said Riley. "The Patterson brand will enhance our already solid reputation and bring new opportunities to our business."

    About Patterson Companies, Inc.:
    Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.
    Dental Market
    As Patterson's largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.
    Veterinary Market
    Patterson Veterinary is a leading distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.
    Rehabilitation Market........Ps. It was mentioned this morn there are other applications in MLA,s portfolio, and I must look ...
    Cheers VIN
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.